Once you get a diagnosis of mesothelioma, it can seem that all the news is bad.
But that could be changing.
A new pharmaceutical drug shows promise treating mesothelioma. Called simply HRX9 right now, the medicine prevents cancerous cells from preventing apoptosis, which is how damaged, unhealthy cells die.
According to the developer of the pharmaceutical who now heads up its research, a professor at the Institute of Cancer Therapeutics at the University of Bradford, “There’s a range of drugs which try to force apoptosis in different cancers, but this is the first one to work in mesothelioma.”
A game-changing drug?
This new drug could be a game-changer in the war on mesothelioma, which remains stubbornly resistant to chemotherapy. It strikes the HOX gene that enables cells to rapidly divide in embryos. Usually deactivated in adults, cancers like mesothelioma can turn them back on and cause them to replicate.
The drug has been tried in Great Britain and shows some definite promise as another tool in the arsenal to combat mesothelioma.
While it is too early to predict how the drug might affect mesothelioma mortality rates, it does show promise for treating a disease that claims far too many lives. Although fewer people are being exposed here in the United States, the rates of exposure still remain high in developing countries that still use asbestos to build.
If you are living with mesothelioma, you may wish to ask your oncologist to keep you in mind for any future drug trials of HRX9.
On another front, you can take legal steps to seek compensation from the former employers whose safety lapses and lax practices led to your asbestos exposure.
Free consultation: Contact a lawyer from The Gori Law Firm to schedule a free consultation. Complete our online contact form to set up a time to talk with one of our attorneys.
Source: Drug Discovery & Development, “New Drug Hope for Mesothelioma,” March 15, 2016